Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.

MLA

Petta, Salvatore, et al. “Time Course of Insulin Resistance during Antiviral Therapy in Non-Diabetic, Non-Cirrhotic Patients with Genotype 1 HCV Infection.” Antiviral Therapy, vol. 14, no. 5, 2009, pp. 631–39. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=19704165&authtype=sso&custid=ns315887.

APA

Petta, S., Cammà, C., Di Marco, V., Cabibi, D., Ciminnisi, S., Caldarella, R., Licata, A., Massenti, M. F., Marchesini, G., & Craxì, A. (2009). Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection. Antiviral Therapy, 14(5), 631–639.

Chicago

Petta, Salvatore, Calogero Cammà, Vito Di Marco, Daniela Cabibi, Stefania Ciminnisi, Rosalia Caldarella, Anna Licata, Maria Fatima Massenti, Giulio Marchesini, and Antonio Craxì. 2009. “Time Course of Insulin Resistance during Antiviral Therapy in Non-Diabetic, Non-Cirrhotic Patients with Genotype 1 HCV Infection.” Antiviral Therapy 14 (5): 631–39. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=19704165&authtype=sso&custid=ns315887.